Regulatory Environment Shaping the ADME Toxicology Testing Market
The regulatory landscape plays a pivotal role in shaping the ADME Toxicology Testing Market. Agencies like the FDA, EMA, and PMDA are enforcing stringent preclinical safety evaluation standards that mandate thorough ADME profiling.
Harmonization efforts between different regulatory bodies are underway to streamline testing protocols and reduce redundant studies. This evolving framework encourages adoption of novel testing methods such as in vitro and in silico approaches, accelerating drug development timelines while ensuring safety compliance.
3 Views